A Reprogramming Histone

The scientist who pioneered cloning has found that a histone may act as a cellular reset button.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wikimedia, Toni BarrosIn the 1996 experiment that created the famous sheep Dolly, researchers swapped the nucleus of an unfertilized egg with that of a differentiated adult cell, which rebooted the adult nucleus to create the first cloned mammal. Now, John B. Gurdon of the Gurdon Institute in Cambridge and colleagues—who developed the technique and shared the Nobel Prize in Physiology or Medicine this year—have found that a histone variant, H3.3, plays a central role in transitioning an adult cell’s nucleus to a blank-slate capable of developing into any of the body’s cells.

"Manipulating the H3.3 pathway may provide a way to completely wipe a cell's ‘memory’ and produce a truly pluripotent cell,” geneticist Steven Henikoff, from the Fred Hutchinson Cancer Research Center, said in a press release. The results, published today (October 29) in Epigenetics & Chromatin, could have implications for regenerative medicine and other therapies, he added, which are beginning to use reprogrammed cells but still face difficulties, including low efficiency. “[It] suggests that chromatin is a sticking point preventing artificially induced reprogramming [from] being used routinely in the clinic."

For the experiment, Gurdon and colleagues implanted a nucleus from an adult mouse cell into an enucleated frog egg—similar to his first groundbreaking nuclear transfer experiment in 1962—and added fluorescently labeled histones, around which strands of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Beth Marie Mole

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours